This news release constitutes a "designated
news release" for the purposes of the REIT's prospectus supplement
dated February 3, 2023, to its short
form base shelf prospectus dated February 2,
2023.
TORONTO, Aug. 8, 2023
/CNW/ - Northwest Healthcare Properties Real Estate Investment
Trust (the "REIT" or "Northwest") (TSX: NWH.UN) announced today
several key decisions about its future direction and as part of the
progression of its evolution as a global asset manager.
Board Changes
Northwest has appointed a non-Executive Chair of the Board, in
line with governance best practices. Mr. Dale Klein, formerly Lead Independent Trustee,
is now Non-Executive Chair.
Mr. Paul Dalla Lana has stepped
away from the Board of Trustees and has resigned as Chief Executive
Officer to focus on initiatives at Northwest Value Partners Inc.,
the REIT's largest shareholder. "It has been an honour to lead
Northwest since the beginning," said Mr. Dalla Lana. "I look forward to assisting Craig
and the Board in ensuring a smooth transition."
Ms. Laura King, Trustee, is
appointed Chair of the REIT's Compensation, Governance and
Nominating Committee. Ms. Maureen
O'Connell, Trustee, is appointed Chair of the Audit
Committee.
"On behalf of the Board, we wish to thank Paul for his
leadership and invaluable contributions to Northwest," said Mr.
Klein. "From establishing the REIT, to taking it public in 2010 and
stewarding operations across four continents, Paul has built the
foundation for the business."
Management Stability
Northwest's global leadership team, experienced in healthcare
real estate and asset management, remains to provide stability and
continuity of leadership.
Mr. Craig Mitchell, formerly
President, has been appointed interim CEO. Mr. Mitchell joined
Northwest in 2018 as CEO for Australia and New
Zealand, was a member of the global management team and
assumed a global leadership role with funds and operations when he
was named President in 2020.
Mr. Michael Brady has been
appointed President. Mr. Brady was formerly Executive Vice
President, General Counsel and Corporate Secretary. Mr. Brady
brings decades of experience in the commercial real estate sector
in Canada and globally.
Mr. Shailen Chande is continuing
his role as Chief Financial Officer and will work closely on the
strategic review (see below). In addition to his experience as
Northwest CFO and its predecessor companies, Mr. Chande has worked
in investment banking in the UK and Europe and qualified as a Chartered
Professional Accountant in Canada.
Mr. Peter Riggin continues in his
senior executive role.
Strategic Review
Committee
Northwest is undertaking a broad-based strategic review to
unlock value. The REIT has formed a Strategic Review Committee of
the Board to undertake the strategic review to assess the best
course of action for the REIT's next phase of development and
growth.
Working with management, the Committee will retain a financial
advisor to help assess and more explore the full strategic
alternatives available to the REIT. There is no certainty that any
changes will result from the Committee's review. The REIT does not
intend to comment further on the review until it determines that
additional disclosure is appropriate or required.
About Northwest Healthcare
Properties Real Estate Investment Trust
Northwest Healthcare Properties Real Estate Investment Trust
(TSX: NWH.UN) (Northwest) is an unincorporated, open-ended real
estate investment trust established under the laws of the Province
of Ontario. As at March 31, 2023, the REIT provides investors with
access to a portfolio of high-quality international healthcare real
estate infrastructure comprised of interests in a diversified
portfolio of 233 income-producing properties and 18.6 million
square feet of gross leasable area located throughout major markets
in Canada, the United States, Brazil, Europe, Australia and New
Zealand. The REIT's portfolio of medical office buildings,
clinics, and hospitals is characterized by long-term indexed leases
and stable occupancies. With a fully integrated and aligned senior
management team, the REIT leverages over 300 professionals in 11
offices in eight countries to serve as a long-term real estate
partner to leading healthcare operators.
Forward Looking
Information
Certain statements contained in this news release constitute
forward-looking information within the meaning of applicable
securities laws. In some cases, forward-looking information can be
identified by such terms such as "may," "might," "will," "could,"
"should," "would," "occur," "expect," "plan," "anticipate,"
"believe," "intend," "estimate," "predict," "potential,"
"continue," "likely," "schedule," or the negative thereof or other
similar expressions concerning matters that are not historical
facts. The forward-looking information in this news release
includes statements regarding the REIT's portfolio, the positioning
of the REIT and the strategic review process being undertaken by
the REIT.
The REIT has based these forward-looking statements on factors
and assumptions about future events and financial trends that it
believes may affect its financial condition, financial performance,
business strategy and financial needs.
Although the forward-looking statements contained in this news
release are based upon assumptions that management of the REIT
believe are reasonable based on information currently available to
management, there can be no assurance that actual results will be
consistent with these forward-looking statements. Forward-looking
statements necessarily involve known and unknown risks and
uncertainties, many of which are beyond the REIT's control,
including, among other things, the risks that no changes will
result from the strategic review process and other risks identified
in materials filed under the REIT's profile at www.sedar.com from
time to time. The forward-looking statements in this news release
relate only to events or information as of the date hereof. Except
as required by applicable Canadian securities laws, the REIT
undertakes no obligation to update or revise publicly any
forward-looking statements, whether as a result of new information,
future events or otherwise, after the date on which the statements
are made or to reflect the occurrence of unanticipated events.
Biographies
Dale
Klein, Non-Executive Chair, Board of Trustees
Dale Klein is currently CEO of
Canada ICI Capital Corporation, a real estate finance group he
founded in Edmonton in 1993 that
has offices across Canada and
annual origination volumes in excess of $7.5
billion and assets under management of more than
$5.5 billion. Dale founded and is the
President & CEO of Canada West Limited, a diversified asset
management group with direct investments in commercial real estate.
As a result, he has considerable experience in all aspects of
commercial real estate. Dale was a member of the Edmonton International Airport Board from 2012
to 2020, where he served as Chair of the Audit Committee for 5 of
the 8 years he was on the Board.
Craig
Mitchell, Chief Executive Officer
Craig Mitchell joined Northwest
in 2018 as CEO for Australia and
New Zealand, was a member of the
global management team and assumed a global leadership role with
funds and operations when he was named President in 2020. The
Northwest Board appointed him interim CEO in 2023.
A professional manager with an inclusive leadership style, Mr.
Mitchell has more than 20 years of experience specializing in the
property industry. His previous roles include Executive Director
and Chief Operating Officer of Dexus, an ASX top 50 listed
REIT.
Mr. Mitchell has a Master of Business Administration (Executive)
from the Australian Graduate School of Management, a Bachelor of
Commerce and a Fellow of CPA Australia. He has also completed the
Advanced Management Program at Harvard
University, Boston.
Michael
Brady, President
Mr. Brady joined Northwest in 2006 and, before being named
President in 2023, was the REIT's Executive Vice President and
General Counsel. He has extensive experience in real estate
investments and finance, transaction management, global leadership,
governance and legal matters.
Prior to joining the corporate real estate world, Mr. Brady was
a corporate law partner at two Toronto-based law firms, where he developed
his real estate practice.
Mr. Brady has a Bachelor of Arts (Economics) and a joint
LL.B./Masters of Business Administration from Dalhousie University, Halifax.
Laura
King, Trustee and Chair of the Compensation, Governance and
Nominating Committee
Ms. King's experience centers on remuneration, workforce and
H.R. strategy, diversity and inclusion, risk, and organizational
structure. From 2013 to 2021, Laura served as a member of the
global board of Clifford Chance LLP, a large international law firm
with approximately £2 billion in annual revenue. She also served on
the Remuneration, Risk and Strategy sub-committees of the firm, was
a partner at the firm from 2001 to 2021, specializing in capital
markets bond issuance, securitization, and structured finance, was
the Global Head of Human Resources from 2011 to 2021, was a member
of the global operating committee and was the head of Recruitment,
Inclusion, Global Mobility, and Learning and Development. She
received her B.A. from the University of
British Columbia and her J.D. from the University of Toronto. She is a member of the
United Kingdom Institute of Directors, the International Women's
Forum (London chapter) and the
venture investment group Angel Academe. She attended the
Harvard Business School Executive
leadership training programme for professional services firms.
Laura currently resides in London,
England.
Maureen
O'Connell, Trustee and Chair of the Audit
Committee
Ms. O'Connell is a global business executive, chief
financial officer, and corporate director with experience in
various industries, including technology, professional services,
biotech, pharma, real estate, and insurance. From 2007 to 2017, she
served as the Chief Financial Officer of Scholastic Corporation,
the world's largest publisher and distributor of children's books.
Earlier in her career, Maureen served as President and Chief
Operating Officer of the Gartner Group, a leading research and
advisory company. She also served as an independent director, audit
committee chair, and transaction committee chair at Sucampo
Pharmaceuticals from 2013 to 2018, when Mallinckrodt acquired it in a $1.2 billion transaction. Ms. O'Connell was
previously an independent director at Harte-Hanks Inc. and
previously served on the board of directors of Beazer Homes
USA Inc. Maureen currently serves
as a non-executive director and audit chair of Acacia Research
Corporation, Filament Health Corporation, H.H. Global and ISACA,
and as a non-executive director of Arix Bioscience PLC. She
graduated Magna Cum Laude with a B.S. in Accounting and Economics
(dual major) from New York University
Stern School of Business and is a Certified Public Accountant.
Maureen currently resides in New York,
USA.
SOURCE NorthWest Healthcare Properties Real Estate Investment
Trust